Valuation: Inogen, Inc.

Market Cap 179M 156M 144M 134M 254M 17.01B 258M 1.72B 670M 8.36B 671M 656M 28.82B P/E 2026 *
-8.43x
P/E 2027 * -14.1x
Enterprise Value 179M 156M 144M 134M 254M 17.01B 258M 1.72B 670M 8.36B 671M 656M 28.82B EV / Sales 2026 *
0.48x
EV / Sales 2027 * 0.45x
Free-Float
87.36%
Yield 2026 *
-
Yield 2027 * -
1 day-0.75%
1 week-4.90%
Current month+2.33%
1 month+4.60%
3 months+6.28%
6 months-0.45%
Current year-1.79%
1 week 6.39
Extreme 6.39
7.08
1 month 6.06
Extreme 6.06
7.08
Current year 5.34
Extreme 5.3401
7.67
1 year 5.34
Extreme 5.3401
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
82.35
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 10/11/2023
Director of Finance/CFO 48 06/04/2026
Chief Tech/Sci/R&D Officer - 29/09/2025
Director TitleAgeSince
Director/Board Member 66 06/08/2014
Chairman 65 29/12/2021
Director/Board Member 59 22/03/2022
Date Insider Type Main position Quantity % Market Cap.
06-05Free

Director

28,081 0.1037%
06-05Free

Director

28,081 0.1037%
06-05Free

Director

28,081 0.1037%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-4.90%-11.88%-41.49% 179M
+3.49%+1.36%-29.04%-11.02% 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+55.88%+50.01% 53.78B
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-43.91% 27.49B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
Average +2.52%+3.94%+4.58%-4.34% 53.9B
Weighted average by Cap. +3.31%+3.80%-3.55%+1.05%

Financials

2026 *2027 *
Net sales 369M 323M 297M 277M 525M 35.16B 532M 3.56B 1.38B 17.28B 1.39B 1.36B 59.56B 397M 347M 319M 297M 564M 37.78B 572M 3.83B 1.49B 18.57B 1.49B 1.46B 64B
Net income -21.7M -18.97M -17.43M -16.25M -30.82M -2.07B -31.29M -209M -81.36M -1.02B -81.45M -79.7M -3.5B -13.2M -11.54M -10.6M -9.88M -18.75M -1.26B -19.03M -127M -49.49M -618M -49.55M -48.48M -2.13B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
02/07/26 $6.600 -0.75% 217,411
01/07/26 $6.650 +3.10% 264,418
30/06/26 $6.450 -6.93% 300,204
29/06/26 $6.930 -0.14% 156,043
26/06/26 $6.940 +2.36% 631,619
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.600USD
Average target price
12.67USD
Spread / Average Target
+91.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock